[Effects and mechanism of low frequency stimulation of pedunculopontine nucleus on spontaneous discharges of ventrolateral thalamic nucleus in rats]. 2011

Huan Liu, and Yu-Han Lin, and Jiu-Hua Cheng, and Yue Cai, and Jin-Wen Yu, and Jin Ma, and Dong-Ming Gao
Key Laboratory of Aerospace Medicine, Ministry of Education, Xi'an 710032, China.

Parkinson's disease is a progressive neurodegenerative disorder characterized clinically by rigidity, akinesia, resting tremor and postural instability. It has recently been suggested that low frequency stimulation of the pedunculopontine nucleus (PPN) has a role in the therapy for Parkinsonism, particularly in gait disorder and postural instability. However, there is limited information about the mechanism of low frequency stimulation of the PPN on Parkinson's disease. The present study was to investigate the effect and mechanism of low frequency stimulation of the PPN on the firing rate of the ventrolateral thalamic nucleus (VL) in a rat model with unilateral 6-hydroxydopamine lesioning of the substantia nigra pars compacta. In vivo extracellular recording and microiontophoresis were adopted. The results showed that the firing rate of 60.71% VL neurons in normal rats and 59.57% VL neurons in 6-hydroxydopamine lesioned rats increased with low frequency stimulation of the PPN. Using microiontophoresis to VL neurons, we found the firing rate in VL neurons responded with either an increase or decrease in application of acetylcholine (ACh) in normal rats, whereas with a predominant decrease in M receptor antagonist atropine. Furthermore, the VL neurons were mainly inhibited by application of γ-aminobutyric acid (GABA) and excited by GABA(A) receptor antagonist bicuculline. Importantly, the VL neurons responding to ACh were also inhibited by application of GABA. We also found that the excitatory response of the VL neurons to the low frequency stimulation of the PPN was significantly reversed by microiontophoresis of atropine. These results demonstrate that cholinergic and GABAergic afferent nerve fibers may converge on the same VL neurons and they are involved in the effects of low frequency stimulation of the PPN, with ACh combining M(2) receptors on the presynaptic membrane of GABAergic afferents, which will inhibit the release of GABA in the VL and then improve the symptoms of Parkinson's disease.

UI MeSH Term Description Entries
D008297 Male Males
D010302 Parkinson Disease, Secondary Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42) Atherosclerotic Parkinsonism,Secondary Parkinsonism,Symptomatic Parkinson Disease,Parkinson Disease, Secondary Vascular,Parkinson Disease, Symptomatic,Parkinsonism, Secondary,Parkinsonism, Symptomatic,Secondary Vascular Parkinson Disease,Parkinsonism, Atherosclerotic,Secondary Parkinson Disease,Symptomatic Parkinsonism
D002799 Cholinergic Fibers Nerve fibers liberating acetylcholine at the synapse after an impulse. Cholinergic Fiber,Fiber, Cholinergic,Fibers, Cholinergic
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D000109 Acetylcholine A neurotransmitter found at neuromuscular junctions, autonomic ganglia, parasympathetic effector junctions, a subset of sympathetic effector junctions, and at many sites in the central nervous system. 2-(Acetyloxy)-N,N,N-trimethylethanaminium,Acetilcolina Cusi,Acetylcholine Bromide,Acetylcholine Chloride,Acetylcholine Fluoride,Acetylcholine Hydroxide,Acetylcholine Iodide,Acetylcholine L-Tartrate,Acetylcholine Perchlorate,Acetylcholine Picrate,Acetylcholine Picrate (1:1),Acetylcholine Sulfate (1:1),Bromoacetylcholine,Chloroacetylcholine,Miochol,Acetylcholine L Tartrate,Bromide, Acetylcholine,Cusi, Acetilcolina,Fluoride, Acetylcholine,Hydroxide, Acetylcholine,Iodide, Acetylcholine,L-Tartrate, Acetylcholine,Perchlorate, Acetylcholine
D000200 Action Potentials Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli. Spike Potentials,Nerve Impulses,Action Potential,Impulse, Nerve,Impulses, Nerve,Nerve Impulse,Potential, Action,Potential, Spike,Potentials, Action,Potentials, Spike,Spike Potential
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016627 Oxidopamine A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals. 6-Hydroxydopamine,6-OHDA,Oxidopamine Hydrobromide,Oxidopamine Hydrochloride,6 Hydroxydopamine,Hydrobromide, Oxidopamine,Hydrochloride, Oxidopamine
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D045042 Pedunculopontine Tegmental Nucleus Dense collection of cells in the caudal pontomesencephalic tegmentum known to play a role in the functional organization of the BASAL GANGLIA and in the modulation of the thalamocortical neuronal system. Nucleus Tegmentalis Pedunculopontinus,Nucleus, Pedunculopontine Tegmental,Tegmental Nucleus, Pedunculopontine

Related Publications

Huan Liu, and Yu-Han Lin, and Jiu-Hua Cheng, and Yue Cai, and Jin-Wen Yu, and Jin Ma, and Dong-Ming Gao
July 2015, Neuroscience letters,
Huan Liu, and Yu-Han Lin, and Jiu-Hua Cheng, and Yue Cai, and Jin-Wen Yu, and Jin Ma, and Dong-Ming Gao
June 2019, Neuromodulation : journal of the International Neuromodulation Society,
Huan Liu, and Yu-Han Lin, and Jiu-Hua Cheng, and Yue Cai, and Jin-Wen Yu, and Jin Ma, and Dong-Ming Gao
October 1964, Archives of neurology,
Huan Liu, and Yu-Han Lin, and Jiu-Hua Cheng, and Yue Cai, and Jin-Wen Yu, and Jin Ma, and Dong-Ming Gao
May 2009, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Huan Liu, and Yu-Han Lin, and Jiu-Hua Cheng, and Yue Cai, and Jin-Wen Yu, and Jin Ma, and Dong-Ming Gao
October 2010, Journal of neurology, neurosurgery, and psychiatry,
Huan Liu, and Yu-Han Lin, and Jiu-Hua Cheng, and Yue Cai, and Jin-Wen Yu, and Jin Ma, and Dong-Ming Gao
February 2018, Neurourology and urodynamics,
Huan Liu, and Yu-Han Lin, and Jiu-Hua Cheng, and Yue Cai, and Jin-Wen Yu, and Jin Ma, and Dong-Ming Gao
June 2015, Journal of neurology, neurosurgery, and psychiatry,
Huan Liu, and Yu-Han Lin, and Jiu-Hua Cheng, and Yue Cai, and Jin-Wen Yu, and Jin Ma, and Dong-Ming Gao
January 2014, World neurosurgery,
Huan Liu, and Yu-Han Lin, and Jiu-Hua Cheng, and Yue Cai, and Jin-Wen Yu, and Jin Ma, and Dong-Ming Gao
April 2009, Neuroscience letters,
Huan Liu, and Yu-Han Lin, and Jiu-Hua Cheng, and Yue Cai, and Jin-Wen Yu, and Jin Ma, and Dong-Ming Gao
January 2009, Journal of neural transmission (Vienna, Austria : 1996),
Copied contents to your clipboard!